Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1996 Aug;87(8):837–842. doi: 10.1111/j.1349-7006.1996.tb02108.x

Expression of Adhesion Molecules on Myeloma Cells

Tetsuya Tatsumi 1,✉, Chihiro Shimazaki 1, Hideo Goto 1, Shin‐ichi Araki 1, Yoshikazu Sudo 1, Noboru Yamagata 1, Eishi Ashihara 1, Tohru Inaba 2, Naohisa Fujita 2, Masao Nakagawa 1
PMCID: PMC5921175  PMID: 8797890

Abstract

We investigated the expression of adhesion molecules including LFA‐1α (CD11a), Mac‐1 (CD11b), LFA‐1β (CD18), VLA‐β1, (CD29), H‐CAM (CD44), VLA‐4 (CD49d), VLA‐5 (CD49e), ICAM‐1 (CD54), N‐CAM (CD56), LFA‐3 (CD58), VNR‐β (CD61), and LECAM‐1 (CD62L) on fresh myeloma cells and human myeloma cell lines. By two‐color flow cytometric analysis with anti‐CD38 antibody, we demonstrated that myeloma cells were located in the strongly CD38‐positive (CD38++) fractions. Fresh myeloma cells were obtained from 28 patients with multiple myeloma (MM) and 3 patients with plasma cell leukemia (PCL). All myeloma cells expressed VLA‐4 on their surface. Most of the myeloma cells also expressed VLA‐5, ICAM‐1, and LFA‐3. H‐CAM was strongly expressed in 3 cases of PCL and 2 cases of aggressive myeloma, and moderately expressed in other MMs. N‐CAM was expressed in 68% of MMs, but none of the 3 PCLs. LFA‐1 was expressed in two cases of aggressive myeloma, but not expressed in other non‐aggressive myelomas. Most of the myeloma cells did not express Mac‐1, VNR‐β, or LECAM‐1. These results suggest that VLA‐4, VLA‐5, ICAM‐1, LFA‐3, and H‐CAM are involved in cellular interaction and migration in MM, and that the expression of N‐CAM and LFA‐1 varies with disease activity in MM.

Keywords: Adhesion molecule, Immunophenotypic analysis, Myeloma cell

Full Text

The Full Text of this article is available as a PDF (383.0 KB).

REFERENCE

  • 1.Bergui , L. , Schema , M. , Gaidano , G. , Riva , M. and Caligalis‐Cappio , F.Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma . J. Exp. Med ., 170 , 613 – 619 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Goto , H. , Shimazaki , C. , Ashihara , E. , Ohkawa , K. , Oku , N. , Inaba , T. , Murakami , S. , Fujita , N. and Nakagawa , M.Effects of interleukin‐3 and interleukin‐6 on peripheral blood cells from multiple myeloma patients and their clinical significance . Acta Haematol ., 88 , 129 – 135 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 3.Bergsagel , P. L. , Smith , A. M. , Szczepek , A. , Mant , M. J. , Belch , A. R. and Pilarski , L. M.In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotype Ig light chain . Blood , 85 , 436 – 447 ( 1995. ). [PubMed] [Google Scholar]
  • 4.Caligaris‐Cappio , F. , Bergui , L. , Gregoretti , M. G. , Gaidano , G. , Gaboli , M. , Schena , M. , Zsllone , A. Z. and Marchisio , P. C.Role of bone marrow stromal cells in the growth of human multiple myeloma . Blood , 77 , 2688 – 2693 ( 1991. ). [PubMed] [Google Scholar]
  • 5.Roldan , E. , Garcia‐Pardo , A. and Brieva , J. A.VLA‐4‐fibronection interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion . J. Exp. Med ., 175 , 1739 – 1747 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tang , J. , Scott , G. and Ryan , D. H.Subpopulations of bone marrow fibroblasts support VLA‐4‐mediated migration of B‐cell precursors . Blood , 82 , 3415 – 3423 ( 1993. ). [PubMed] [Google Scholar]
  • 7.Kalasz , V. , Pap , T. , Csanaky , G. and Kelenyi , G.Endothelial cell receptors on leukemic cells . Leuk. Res ., 13 , 863 – 868 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 8.Tsutani , H. , Sugiyama , T. , Shimizu , S. , Iwasaki , H. , Ueda , T. , Ozaki , K. , Konda , S. and Nakamura , T.Discordant LFA‐1/ICAM‐1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma . Am. J. Hematol ., 42 , 299 – 304 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9.Uchiyama , H. , Barut , B. A. , Mohrbacher , A. F. , Chauhan , D. and Anderson , K. C.Adhesion of human myelomaderived cell lines to bone marrow stromal cells stimulates interleukin‐6 secretion . Blood , 82 , 3712 – 3720 ( 1993. ). [PubMed] [Google Scholar]
  • 10.Lokhorst , H. M. , Lamme , T. , De Smet , M. , Klein , S. , De Weger , R. A. , van Oers , R. and Bloem , A. C.Primary tumor cells of myeloma patients induce interleukin‐6 secretion in long‐term bone marrow cultures . Blood , 84 , 2269 – 2277 ( 1994. ). [PubMed] [Google Scholar]
  • 11.van Camp , B. , Durie , B. G. M. , Spier , C. , De Wael , E. M. , van Riet , I. , Vela , E. , Frutigar , Y. , Richter , L. and Grogan , T. M.Plasma cells in multiple myeloma express a natural killer cell‐associated antigen: CD56 (NKH‐1; Leu‐19) . Blood , 76 , 377 – 382 ( 1990. ). [PubMed] [Google Scholar]
  • 12.Drach , L. , Gattringer , C. and Huber , H.Expression of the neural cell adhesion molecule (CD56) by human myeloma cells . Clin. Exp. Immunol ., 83 , 418 – 422 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.van Riet , I. , De Waele , M. , Remels , L. , Lacor , P. , Schots , R. and van Camp , B.Expression of cytoadhesion molecules (CD56, CD54, CD18, CD29) by myeloma plasma cells . Br. J. Haematol ., 79 , 421 – 427 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 14.Barker , H. F. , Hamilton , M. S. , Ball , J. , Drew , M. and Franklin , I. M.Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells . Br. J. Haematol ., 81 , 331 – 335 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 15.Leo , R. , Boeker , M. , Peest , D. , Hein , R. , Bartl , R. , Gessner , J. E. , Selbach , J. , Wacker , G. and Deicher , H.Multiparameter analysis of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells . Ann. Hematol ., 64 , 132 – 139 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 16.Uchiyama , H. , Barut , B. A. , Chauhan , D. , Cannistra , S. A. and Anderson , K. C.Characterization of adhesion molecules on human myeloma cell lines . Blood , 80 , 2306 – 2314 ( 1992. ). [PubMed] [Google Scholar]
  • 17.Pellat‐Deceunynck , C. , Brille , S. , Puthier , D. , Rapp , M. J. , Harousseau , J. L. , Bataille , R. and Amiot , M.Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization . Cancer Res ., 55 , 3647 – 3653 ( 1995. ). [PubMed] [Google Scholar]
  • 18.Vacca , A. , Di Loreto , M. , Ribatti , D. , Di Stefano , R. , Gadaleta‐Caldarola , G. , Iodice , G. , Caloro , D. and Dammacco , F.Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA‐1, VLA‐4, LAM‐1, and CD44 . Am. J. Hematol ., 50 , 9 – 14 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 19.Jalkanen , S. , Joensuu , H. and Klemi , P.Prognostic value of lymphocyte homing receptor and S phase fraction in non‐Hodgkin's lymphoma . Blood , 75 , 1549 – 1556 ( 1990. ). [PubMed] [Google Scholar]
  • 20.Stauder , R. , Greil , R. , Schulz , T. F. , Thaler , J. , Gattringer , C. , Radaskiewicz , T. , Dierich , M. P. and Huber , H.Expression of leucocyte function‐associated antigen‐1 and 7F 7‐antigen, an adhesion molecule related to intercellular adhesion molecule‐1 (ICAM‐1) in non‐Hodgkin's lymphomas and leukaemias: possible influence on growth pattern and leukaemic behavior . Clin. Exp. Immunol ., 77 , 234 – 238 ( 1989. ). [PMC free article] [PubMed] [Google Scholar]
  • 21.Horst , E. , Meijer , C. J. L. M. , Radaskiewicz , T. , Ossekoppele , G. J. , van Krieken , J. H. J. M. and Pals , S. T.Adhesion molecules in the prognosis of diffuse large‐cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA‐1 (CD11a/18), and ICAM‐1 (CD54) . Leukemia , 4 , 595 – 599 ( 1990. ). [PubMed] [Google Scholar]
  • 22.Suchman , A. L. , Coleman , M. , Mouradian , J. A. , Wolf , D. J. and Saletan , S.Aggressive plasma cell myeloma: a terminal phase . Arch. Intern. Med ., 141 , 1315 – 1320 ( 1981. ). [PubMed] [Google Scholar]
  • 23.Durie , B. G. M. and Salmon , S. E.A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival . Cancer , 36 , 842 – 854 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 24.Shimazaki , C. , Ashihara , E. , Ohkawa , K. , Goto , H. , Oku , N. , Inaba , T. , Ito , K. , Fujita , N. , Nakagawa , M. and Kawa , K.Establishment of myeloma cell line from a patient with aggressive myeloma . Int. J. Hematol ., 55 ( Suppl. 1 ), 242 ( 1992. ). [Google Scholar]
  • 25.Goto , H. , Shimazaki , C. , Tatsumi , T. , Yamagata , N. , Fujita , N. , Tsuchiya , M. , Koishihara , Y. , Ohsugi , Y. and Nakagawa , M.Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin‐6 through an autocrine mechanism . Leukemia , 9 , 711 – 718 ( 1995. ). [PubMed] [Google Scholar]
  • 26.Greipp , P. R. , Raymond , N. M. , Kyle , R. A. and O'Fallon , W. M.Multiple myeloma: significance of plasmablastic subtype in morphological classification . Blood , 65 , 305 – 310 ( 1985. ). [PubMed] [Google Scholar]
  • 27.Ruiz‐Arguelles , G. J. , Katzmann , J. A. , Greipp , P. R. , Gonchoroff , N. , Garton , J. P. and Kyle , R. A.Multiple myeloma: circulating lymphocytes that express plasma cell antigens . Blood , 64 , 352 – 356 ( 1984. ). [PubMed] [Google Scholar]
  • 28.Shimazaki , C. , Fried , J. , Perez , A. G. , Scheinberg , D. A. , Atzpodien , J. , Wang , C. Y. , Wisniewolski , R. and Clarkson , B. D.Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma . Acta Haematol ., 83 , 123 – 129 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 29.Harada , H. , Kawano , M. M. , Huang , N. , Harada , Y. , Iwato , K. , Tanabe , O. , Tanaka , H. , Sakai , A. , Asaoku , H. and Kuramoto , A.Phenotypic differences of normal plasma cells from mature myeloma cells . Blood , 81 , 2658 – 2663 ( 1993. ). [PubMed] [Google Scholar]
  • 30.Kawano , M. M. , Huang , N. , Harada , H. , Harada , Y. , Sakai , A. , Tanaka , H. , Iwato , K. and Kuramoto , A.Identification of immature and mature myeloma cells in the bone marrow of human myelomas . Blood , 82 , 564 – 570 ( 1993. ). [PubMed] [Google Scholar]
  • 31.Huang , N. , Kawano , M. M. , Harada , H. , Harada , Y. , Sakai , A. , Kuramoto , A. and Niwa , O.Heterogeneous expression of a novel MPC‐1 antigen on myeloma cells: possible involvement of MPC‐1 antigen in the adhesion of mature myeloma cells to bone marrow stromal cells . Blood , 82 , 3721 – 3729 ( 1993. ). [PubMed] [Google Scholar]
  • 32.Ahsmann , E. L. M. , Lokhorst , H. M. , Dekker , A. W. and Bloem , A. C.Lymphocyte function‐associated antigen‐1 expression on plasma cells correlates with tumor growth in multiple myeloma . Blood , 79 , 2068 – 2075 ( 1992. ). [PubMed] [Google Scholar]
  • 33.Kim , I. , Uchiyama , H. , Chauhan , D. and Anderson , K. C.Cell surface expression and functional significance of adhesion molecules on human myeloma‐derived cell lines . Br. J. Haematol ., 87 , 483 – 493 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 34.Okada , T. and Hawley , R. G.Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements . Int. J. Cancer , 63 , 823 – 830 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 35.Yamagata , N. , Shimazaki , C. , Tatsumi , T. , Goto , H. and Nakagawa , M.Cell adhesion receptors on neoplastic plasma cells (author's reply) . Am. J. Hematol ., 49 , 361 – 363 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 36.Schwab , G. , Siegall , C. B. , Aaden , L. A. , Neckers , L. M. and Nordan , R. P.Characterization of an interleukin‐6‐mediated autocrine growth loop in the myeloma cell lines, U266 . Blood , 77 , 587 – 593 ( 1991. ). [PubMed] [Google Scholar]
  • 37.Klein , B. , Zhang , X. G. , Jourdan , M. , Content , J. , Houssiau , F. , Aadan , L. , Piechaczyk , M. and Bataille , R.Paracrine rather than autocrine regulation of myeloma‐cell growth and differentiation by interleukin‐6 . Blood , 73 , 517 – 562 ( 1989. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES